Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Madrid, Spain.
Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Eur Heart J. 2022 Feb 3;43(5):377-386. doi: 10.1093/eurheartj/ehab884.
Since last year's report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around the globe. In our yearly review, we shall revisit the developments in percutaneous coronary intervention (PCI), structural heart interventions, and adjunctive pharmacotherapy.
自去年在《欧洲心脏杂志》上发表报告以来，我们见证了介入心脏病学各个方面的重大进展。值得注意的是，介入心脏病学的实践是在 COVID-19 大流行的连续浪潮中进行的，这仍然是全球所有医疗保健专业人员的主要负担。在我们的年度回顾中，我们将重新探讨经皮冠状动脉介入治疗（PCI）、结构性心脏介入治疗和辅助药物治疗的发展。
